Get started
Author

Inass Shaltout

Observed names: I. Shaltout, INASS SHALTOUT, Inass F. Shaltout, Inass Fahiem Shaltout, Shaltout, Inass
Institution: Cairo University
ORCID: 0000-0003-1264-4922
Observed ORCID: 0000-0003-1264-4922
OpenAlex ID: A5022308084
Diabetes and Ramadan: Practical guidelines 2021
2022 · Mohamed Hassanein, Bachar Afandi, et al. · Diabetes Research and Clinical Practice · 226
PDF
The effect of vildagliptin relative to sulphonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: the VIRTUE study
2013 · M. Al‐Arouj, A. A. K. Hassoun, et al. · International Journal of Clinical Practice · 67
PDF
The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes
2021 · Mohamed Hassanein, Zanariah Hussein, et al. · Diabetes Research and Clinical Practice · 57
PDF
A real-world study in patients with type 2 diabetes mellitus treated with gliclazide modified-release during fasting: DIA-RAMADAN
2020 · Mohamed Hassanein, Saud Al Sifri, et al. · Diabetes Research and Clinical Practice · 43
PDF
Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey
2020 · Mohamed Hassanein, Reem M. Alamoudi, et al. · Diabetes Research and Clinical Practice · 42
PDF
Real-world safety and effectiveness of insulin glargine 300 U/mL in participants with type 2 diabetes who fast during Ramadan: The observational ORION study
2020 · Mohamed Hassanein, Mehmet Akif Buyukbese, et al. · Diabetes Research and Clinical Practice · 38
PDF
A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease
2024 · Huai Zhang, Giovanni Targher, et al. · Hepatology International · 34
Use of SGLT2 inhibitors during Ramadan: An expert panel statement
2020 · Mohamed Hassanein, Alaaeldeen Bashier, et al. · Diabetes Research and Clinical Practice · 30
PDF
An update on the current characteristics and status of care for Muslims with type 2 diabetes fasting during Ramadan: the DAR global survey 2022
2024 · Mohamed Hassanein, Sueziani Binte Zainudin, et al. · Current Medical Research and Opinion · 25
Real-world safety and effectiveness of iGlarLixi in people with type 2 diabetes who fast during Ramadan: The SoliRam observational study
2023 · Mohamed Hassanein, Rachid Malek, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 16
Culturally based pre-Ramadan education increased benefits and reduced hazards of Ramadan fasting for type 2 diabetic patients
2020 · Inass Shaltout, Abir Zakaria, et al. · Journal of Diabetes & Metabolic Disorders · 15
PDF
Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global survey
2023 · Mohamed Hassanein, Sanobia Yousuf, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 14
PDF
Fasting Ramadan in patients with T1DM – Saudi Arabia versus other countries during the COVID-19 pandemic
2022 · Reem M. Alamoudi, Naji J. Aljohani, et al. · Diabetes & Metabolic Syndrome Clinical Research & Reviews · 14
Risk Stratification in People with Diabetes for Fasting During Ramadan: Consensus from Arabic Association for the Study of Diabetes and Metabolism
2023 · Inass Shaltout, Amr Mahmoud Abdelwahab, et al. · Current Diabetes Reviews · 13
Arabic Association for the Study of Diabetes and Metabolism (AASD) endorsing the MAFLD definition of fatty liver disease
2021 · Inass Shaltout, Hessa Alkandari, et al. · Journal of Hepatology · 11
PDF
Safety and Effectiveness of Concomitant iGlarLixi and SGLT-2i Use in People with T2D During Ramadan Fasting: A SoliRam Study Sub-analysis
2024 · Mohamed Hassanein, Rachid Malek, et al. · Diabetes Therapy · 10
PDF
Ramadan fasting among adults with type 2 diabetes in five geographically different regions of the world: The DAR 2020 global survey
2024 · Mohamed Hassanein, M Yakoob Ahmedani, et al. · Diabetes Epidemiology and Management · 10
Effect of Vildagliptin Versus Sulfonylurea in Muslim Patients with Type 2 Diabetes Fasting During Ramadan in Egypt: Results from VIRTUE Study
2016 · Mohamed Khattab, Khalifa Mahmoud, et al. · Diabetes Therapy · 10
PDF
Effects of vildagliptin relative to sulfonylureas in Muslim patients with type 2 diabetes fasting during Ramadan: influence of age and treatment with/without metformin in the VIRTUE study
2016 · Ahmed Hassoun, Md Faruque Pathan, et al. · Diabetes Metabolic Syndrome and Obesity · 9
PDF
Metabolic/bariatric surgery optimization: a position statement by Arabic association for the study of diabetes and metabolism (AASD)
2025 · Amin Roshdy Soliman, Hesham Magd eldin Saleem, et al. · Diabetology & Metabolic Syndrome · 7
PDF
Global multi-societies endorsement of the MAFLD definition
2024 · Mohamed Alboraie, Tawesak Tanwandee, et al. · Annals of Hepatology · 7
Effect of carvedilol versus nebivolol on insulin resistance among non-diabetic, non-ischemic cardiomyopathy with heart failure
2020 · Yasser Gaber Metwally, Heba Kamal Sedrak, et al. · The Egyptian Heart Journal · 7
PDF
Exploring obesity-related endocrine disorders beyond diabetes: a narrative review
2024 · Amr Abel Hady El Meligi, Rabab Mahmoud Ahmed, et al. · The Egyptian Journal of Internal Medicine · 6
PDF
Descriptive Regional Subanalysis of a Real-World Study in Patients with Type 2 Diabetes Treated with Gliclazide MR During Fasting: DIA-RAMADAN
2021 · Mohamed Hassanein, Saud Al Sifri, et al. · Diabetes Therapy · 5
PDF
Non-diabetic hypoglycemia: bridging gaps in diagnosis and treatment: a position statement report by the Arabic Association for the Study of Diabetes and Metabolism (AASD)
2025 · Amin Roshdy Soliman, Rabab Mahmoud Ahmed, et al. · Cardiovascular Diabetology – Endocrinology Reports · 3
Works count: 55
Citation count: 744
H-index: 13
I10-index: 18
Year
Topic
Type